On September 22, 2020 ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, reported that Pierre Belichard, Chief Executive Officer, and Christophe Bonny, Chief Scientific Officer, will present at the Jefferies Virtual Next Generation IBD Therapeutics Summit, which will take place September 23-24, 2020 (Press release, Enterome, SEP 22, 2020, View Source [SID1234565504]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation, in the form of a live fireside chat, will take place on Wednesday, September 23, at 11:30-12:10 Eastern Daylight Time.